Serebral Palsi’de Tanı ve Tedavi
Özet
Serebral palsi, gelişmekte olan beyindeki ilerleyici olmayan hasara bağlı oluşan, çocukluk çağının en yaygın nörogelişimsel motor bozukluğudur. Genetik ve çevresel faktörlerin karmaşık etkileşimiyle ortaya çıkan bu durum, spastisite, distoni veya ataksi gibi çeşitli klinik tablolara yol açar. Tanı; ayrıntılı klinik öykü, nörolojik muayene ve görüntüleme yöntemleriyle konulurken, tedavi süreci multidisipliner rehabilitasyon ve kişiselleştirilmiş destek yaklaşımlarını içerir. Erken tanı ve proaktif müdahale, beyin plastisitesinden yararlanarak fonksiyonel sonuçları iyileştirmek için kritiktir.
Cerebral palsy is the most common chronic neurodevelopmental motor disorder in childhood, resulting from non-progressive damage to the developing brain. Often caused by complex interactions between genetic and environmental factors, it manifests in various clinical forms such as spasticity, dystonia, or ataxia. Diagnosis relies on detailed clinical history, neurological examination, and neuroimaging, while management requires a multidisciplinary, individualized rehabilitation approach. Early diagnosis and proactive intervention are critical to maximizing neuroplasticity and improving long-term functional outcomes.
Referanslar
Rosenbaum B, Paneth N, Allen L, Goldstein M, Bax M. A report: The definition and classification of cerebral palsy. Dev Med Child Neurol 2007;(Suppl No 109)49:8-14.
Michael-Asalu A, Taylor G, Campbell H, Lelea LL, Kirby RS. Cerebral palsy: diagnosis, epidemiology, genetics, and clinical update. Adv Pediatr. 2019;66:189-208.
Novak I, Morgan C, Adde L, et al. Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment. JAMA Pediatr. 2017;171(9):897-907.
Oskoui M, Shevell MI, Swaiman KF. Cerebral palsy. In: Swaiman KF, Finkel RS, Ashwal S, Gropman AL, Ferriero DM, Pearl PL, Schor NF, Shevell MI, eds. Swaiman’s Pediatric Neurology Principles and Practice. 6th Ed. China: Elsevier; 2018. p.734-40.
Novak I. Evidence-based diagnosis, health care, and rehabilitation for children with cerebral palsy. J Child Neurol. 2014;29(8):1141-56.
Shaunak M, Kelly VB. Cerebral palsy in under 25 s: assessment and management (NICE Guideline NG62). Arch Dis Child Educ Pract Ed. 2018;103(4):189-93.
Yakut A. Serebral palsi etiolojisi ve risk faktörleri. İçağasıoğlu DF, Sönmez FM, editörler. Serebral Palsi. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.1-3.
Serdaroğlu A, Cansu A, Ozkan S, Tezcan S. Prevalence of cerebral palsy in Turkish children between the ages of 2 and 16 years. Dev Med Child Neurol. 2006;48(6):413-6.
Graham D, Paget SP, Wimalasundera N. Current thinking in the health care management of children with cerebral palsy. Med J Aust. 2019;210(3):129-35.
Romeo DM, Sini F, Brogna C, Albamonte E, Ricci D, Mercuri E. Sex differences in cerebral palsy on neuromotor outcome: a critical review. Dev Med Child Neurol. 2016 Aug;58(8):809-13.
Gulati S, Sondhi V. Cerebral palsy: an overview. Indian J Pediatr. 2018;85(11):1006-16.
Pearson TS, Pons R, Ghaoui R, Sue CM. Genetic mimics of cerebral palsy. Mov Disord. 2019;34(5):625-36.
https://www.cdc.gov/ncbddd/cp/causes.html (Ulaşma tarihi 18.10.2021).
Marret S, Vanhulle C, Laquerriere A. Pathophysiology of cerebral palsy. Handb Clin Neurol. 2013;111:169-76.
Çobanoğulları Direk M, Okuyaz Ç. Serebral palsi ve plastisite. İçağasıoğlu DF, Sönmez FM, editörler. Serebral Palsi. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.19-23.
Wang R, Gaverth J, Herman PA. Changes in the neural and non-neural related properties of the spastic wrist flexors after treatment with botulinum toxin a in post-stroke subjects: an optimization study. Front Bioeng Biotechnol. 2018;6:73.
Ashwal S, Russman BS, Blasco PA, et al.; Quality Standards Subcommittee of the American Academy of Neurology; Practice Committee of the Child Neurology Society. Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2004;62(6):851-63.
Yarar C. Serebral palsinin erken tanısında ilkel refleksler ve postural reaksiyonlar. Osmangazi Tıp Dergisi, 2016;38 (Özel Sayı 1): p.71-6.
Ölçülü CB, Gökben S. Serebral palside erken tanı ve ayırıcı tanı. İçağasıoğlu DF, Sönmez FM, editörler. Serebral palsi. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.29-34.
Surveillance of Cerebral Palsy in Europe. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE). Dev Med Child Neurol. 2000;42(12):816-24.
SCPE CD, English-Turkish edition, 2009; çeviri editörleri Aysun S, Yakut A.
Cadwgan J, Goodwin J, Fairhurst C. Fifteen-minute consultation: modern-day art and science of managing cerebral palsy. Arch Dis Child Educ Pract Ed. 2019;104(2):66-73.
Parlak Ş, Çoban Çiftçi G. Serebral palside radyoloji. İçağasıoğlu DF, Sönmez FM, editörler. Serebral Palsi. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.58-66.
Vancamp P, Demeneix BA, Remaud S. Monocarboxylate transporter 8 deficiency: delayed or permanent hypomyelination? Front Endocrinol (Lausanne). 2020;11:283.
Kubaski F, de Oliveira Poswar F, Michelin-Tirelli K, et al. Diagnosis of mucopolysaccharidoses. Diagnostics (Basel). 2020;10(3):172.
Byrne R, Noritz G, Maitre NL; NCH Early Developmental Group. Implementation of early diagnosis and intervention guidelines for cerebral palsy in a high-risk infant follow-up clinic. Pediatr Neurol. 2017;76:66-71.
Yarar C. Serebral palside karşılaşılan diğer sorunlar ve yaklaşım. İçağasıoğlu DF, Sönmez FM, editörler. Serebral Palsi. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.86-94.
Kerem Günel M, Seyhan Bıyık K, Çankaya Ö. Serebral palside (Re)habilitasyon. İçağasıoğlu DF, Sönmez FM, editörler. Serebral Palsi. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.79-85.
Boychuck Z, Andersen J, Bussieres A, et al. Use of consensus methods to determine the early clinical signs of cerebral palsy. Paediatr Child Health. 2020;25(5):300-7.
Smith M, Kurian MA. The medical management of cerebral palsy. Paediatr Child Health. 2012;22(9):372–6.
Göktaş MA, Özen H.Serebral palsili çocuklarda beslenme. İçağasıoğlu DF, Sönmez FM, editörler. Serebral Palsi. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.52-7.
Romano C, van Wynckel M, Hulst J, et al. European Society for Paediatric Gastroenterology, Hepatology and Nutrition guidelines for the evaluation and treatment of gastrointestinal and nutritional complications in children with neurological impairment. J Pediatr Gastroenterol Nutr. 2017;65(2):242-64.
Vogt H, Hofmann B, Getz L. The new holism: P4 systems medicine and the medicalization of health and life itself. Med Health Care Philos. 2016;19(2):307-23.
Çiftci S, Şeneran H. Serebral palsiye ortopedik yaklaşım. İçağasıoğlu DF, Sönmez FM, editörler. Serebral Palsi. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.67-78.
Rice J. Oral medication use in cerebral palsy. In: Panteliadis CP, ed. Cerebral Palsy. A multidisciplinary Approach. 3rd Ed. Switzerland: Springer; 2018. p.259-67.
İşcan A. Serebral palsi: medikal tedavi. İçağasıoğlu DF, Sönmez FM, editörler. Serebral Palsi. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.35-41.
Çobanoğulları Direk M, Okuyaz Ç. Serebral palsi ve hareket bozuklukları. İçağasıoğlu DF, Sönmez FM, editörler. Serebral Palsi. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.46-51.
Rutz E, Thomason P, Willoughby K, Graham HK. Integrated management in cerebral palsy: musculoskeletal surgery and rehabilitation in ambulatory patients. In: Panteliadis CP, ed. Cerebral Palsy. A multidisciplinary Approach. 3rd Ed. Switzerland: Springer; 2018. p.229-51.
Deda G. Serebral palside botulinum toksini ve diğer tedavi yöntemleri. İçağasıoğlu DF, Sönmez FM, editörler. Serebral Palsi. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.42-5.
Karch D, Heinemann K. Physiotherapeutic interventions: Bobath, Vojta, and motor learning approaches. In: Panteliadis CP, ed. Cerebral Palsy. A multidisciplinary Approach. 3rd Ed. Switzerland: Springer; 2018. p.155-64.
Novak I, Walker K, Hunt RW, Wallace EM, Fahey M, Badawi N. Concise Review: Stem Cell Interventions for People With Cerebral Palsy: Systematic Review With Meta-Analysis. Stem Cells Transl Med. 2016;5(8):1014-25.
Zhang Y, Wu J, Xiao N, Li B. Hyperbaric oxygen therapy ıs beneficial for the ımprovement of clinical symptoms of cerebral palsy: a systematic review and meta-analysis. Complement Med Res. 2021 Sep 17:1-14.
Nasiri J, Safavifar F. Effect of cerebrolysin on gross motor function of children with cerebral palsy: a clinical trial. Acta Neurol Belg. 2017;117(2):501-5.
Ukhanova TA, Gorbunov FE. [Efficacy of reflexology in the combination with neuroprotective treatment in hemiparetic form of children cerebral palsy]. Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(7):28-31.
Novak I, McIntyre S, Morgan C, et al. A systematic review of interventions for children with cerebral palsy: state of the evidence. Dev Med Child Neurol. 2013;55(10):885-910.
Gilson KM, Davis E, Reddihough D, Graham K, Waters E. Quality of life in children with cerebral palsy: implications for practice. J Child Neurol. 2014;29(8):1134-40.
Graham HK, Rosenbaum P, Paneth N, et al. Cerebral palsy. Nat Rev Dis Primers. 2016;2:15082.
Colver A, Fairhurst C, Pharoah PO. Cerebral palsy. Lancet. 2014;383(9924):1240-9.
Vitrikas K, Dalton H, Breish D. Cerebral palsy: an overview. Am Fam Physician. 2020;101(4):213-20.
Taft LT. Cerebral palsy. Pediatr Rev. 1995;16:411-8.
Dan B. Animal models of cerebral palsy. Dev Med Child Neurol. 2020;62(1):4.
Pan Y, Lei X, Zhang Y. Association predictions of genomics, proteinomics, transcriptomics, microbiome, metabolomics, pathomics, radiomics, drug, symptoms, environment factor, and disease networks: A comprehensive approach. Med Res Rev. 2021 Aug 4. doi: 10.1002/med.21847. Epub ahead of print. PMID: 34346083.
